TrkA-positive PC OD measurements showed a trend toward a decrease in AD and DS compared to HC subjects but did not reach significance when analyzed with (Kruskall–Wallis, p = 0.065) or without DSD– (Kruskall–Wallis, p = 0.059) cases. This evidence concerns the gene NTRK1 and Alzheimer disease.